CLASS II Drug recall · Reported 1 Jun 2022 · FDA Enforcement Report

Losartan HCTZ 100/12.5 mg recalled by RemedyRepack

RemedyRepack is recalling Losartan HCTZ 100/12.5 mg, distributed in Florida, South Carolina, Virginia. The recall was initiated on 2 May 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # B1364261-092721, exp. date 09/30/2022 B1377667-100521, exp. date 10/31/2022 B1412576-102621, exp. date 10/31/2022 B1436925-111321, exp. date 11/30/2022
Quantity recalled30 bottles/90 count = 2,700 tablets

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0887-2022
FDA event ID
90127
Recalling firm
RemedyRepack, Indiana, PA
Classification
Class II
Status
Terminated
Recall initiated
2 May 2022
FDA classified
20 May 2022
Reported
1 Jun 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

2 May 2022Recall initiated by company
20 May 2022Classified by FDA+18 days
1 Jun 2022Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Losartan HCTZ 100/12.5 mg, 90 count bottles NDC# 70518-2564-00 Repackaged NDC Original NDC # 68180-0216-09

Where it was distributed

Product was distributed to FL, SC and VA

FloridaSouth CarolinaVirginia

Questions about this recall

Why was it recalled?

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

Which lots are affected?

Lot # B1364261-092721, exp. date 09/30/2022 B1377667-100521, exp. date 10/31/2022 B1412576-102621, exp. date 10/31/2022 B1436925-111321, exp. date 11/30/2022

Where was it sold?

Product was distributed to FL, SC and VA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 90127

This product is part of a recall event; the main page for the event is Losartan HCTZ 100/25 mg recalled by RemedyRepack.

ReportedClassRecallCompanyReasonWhere
CLASS IILosartan HCTZ 100/25 mg recalled by RemedyRepackRemedyRepackPotency & AssayFL, SC, VA

More recalls from RemedyRepack

All 61

Other Losartan Hctz 100 recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IILosartan HCTZ 100/25 mg recalled by RemedyRepackRemedyRepackPotency & AssayFL, SC, VA